Halo Pharmaceutical, Inc.
Pharmaceutical Intermediates
Halo Pharmaceutical, Inc. is a contract development and manufacturing organization (CDMO) specializing in small molecule therapeutics. The company offers end-to-end services including formulation development, clinical supplies, commercial manufacturing, and analytical testing across solid, semi-solid, and oral liquid dosage forms. It operates cGMP facilities in Whippany, New Jersey, and Mirabel, Quebec, Canada, with plans to add sterile injectable manufacturing capabilities in 2026.
